Literature DB >> 8591043

The structure of coxsackievirus B3 at 3.5 A resolution.

J K Muckelbauer1, M Kremer, I Minor, G Diana, F J Dutko, J Groarke, D C Pevear, M G Rossmann.   

Abstract

BACKGROUND: Group B coxsackieviruses (CVBs) are etiologic agents of a number of human diseases that range in severity from asymptomatic to lethal infections. They are small, single-stranded RNA icosahedral viruses that belong to the enterovirus genus of the picornavirus family. Structural studies were initiated in light of the information available on the cellular receptors for this virus and to assist in the design of antiviral capsid-binding compounds for the CVBs.
RESULTS: The structure of coxsackievirus B3 (CVB3) has been solved to a resolution of 3.5 A. The beta-sandwich structure of the viral capsid proteins VP1, VP2 and VP3 is conserved between CVB3 and other picornaviruses. Structural differences between CVB3 and other enteroviruses and rhinoviruses are located primarily on the viral surface. The hydrophobic pocket of the VP1 beta-sandwich is occupied by a pocket factor, modeled as a C16 fatty acid. An additional study has shown that the pocket factor can be displaced by an antiviral compound. Myristate was observed covalently linked to the N terminus of VP4. Density consistent with the presence of ions was observed on the icosahedral threefold and fivefold axes.
CONCLUSIONS: The canyon and twofold depression, major surface depressions, are predicted to be the primary and secondary receptor-binding sites on CVB3, respectively. Neutralizing immunogenic sites are predicted to lie on the extreme surfaces of the capsid at sites that lack amino acid sequence conservation among the CVBs. The ions located on the icosahedral threefold and fivefold axes together with the pocket factor may contribute to the pH stability of the coxsackieviruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8591043     DOI: 10.1016/s0969-2126(01)00201-5

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  94 in total

1.  Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst.

Authors:  S K Tsang; B M McDermott; V R Racaniello; J M Hogle
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Genomic variations in echovirus 30 persistent isolates recovered from a chronically infected immunodeficient child and comparison with the reference strain.

Authors:  J L Bailly; M Chambon; C Henquell; J Icart; H Peigue-Lafeuille
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.

Authors:  Yongning He; Feng Lin; Paul R Chipman; Carol M Bator; Timothy S Baker; Menachem Shoham; Richard J Kuhn; M Edward Medof; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

4.  Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.

Authors:  Amanda D Stuart; Thomas A McKee; Pamela A Williams; Chris Harley; Shuo Shen; David I Stuart; T David K Brown; Susan M Lea
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 5.  Picornavirus uncoating.

Authors:  M S Smyth; J H Martin
Journal:  Mol Pathol       Date:  2002-08

Review 6.  Poliovirus cell entry: common structural themes in viral cell entry pathways.

Authors:  James M Hogle
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

Review 7.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Coxsackievirus B3 infection and its mutation in Keshan disease.

Authors:  Li-Qun Ren; Xiang-Jun Li; Guang-Sheng Li; Zhi-Tao Zhao; Bo Sun; Fei Sun
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

9.  Characterization of Coxsackievirus B4 virus-like particles VLP produced by the recombinant baculovirus-insect cell system expressing the major capsid protein.

Authors:  Ikbel Hadj Hassine; Jawhar Gharbi; Bechr Hamrita; Mohammed A Almalki; José Francisco Rodríguez; Manel Ben M'hadheb
Journal:  Mol Biol Rep       Date:  2020-04-02       Impact factor: 2.316

10.  Discrimination among rhinovirus serotypes for a variant ICAM-1 receptor molecule.

Authors:  Chuan Xiao; Tobias J Tuthill; Carol M Bator Kelly; Lisa J Challinor; Paul R Chipman; Richard A Killington; David J Rowlands; Alister Craig; Michael G Rossmann
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.